Table 2 Clinical stage, Pathological stage and response
NCRT+MIE(n = 44) | MIE alone(n = 63) | |
|---|---|---|
Clinical stage | ||
II 2 (4%) | I 8 (13%) | |
III 25 (57%) | II 51 (81%) | |
IV 17 (39%) | III 4 (6%) | |
Pathological stage | ypTNM | pTNM |
I 21 (47%) | IA 5 (8%) | |
II 5 (11%) | IB 2 (3%) | |
IIIA 5 (11%) | IIA 11 (18%) | |
IIIB 10 (22%) | IIB 19 (31%) | |
IVA 4 (9%) | IIIA 17 (26%) | |
IIIB 7 (11%) | ||
IVA 2 (3%) | ||
Response | PR 19 (43%) | |
CR 21 (48%) | ||
SD 4 (9%) | ||
pCR 13 (29.55%) | ||